Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v7-FR
Language English French
Date Updated 2018-02-07 2018-01-15
Drug Identification Number 00761834 00761834
Brand name DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP
Common or Proper name DOPAMINE HCL 3.2MG/ML DOPAMINE HCL 3.2MG/ML
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients DEXTROSE DOPAMINE HYDROCHLORIDE DEXTROSE DOPAMINE HYDROCHLORIDE
Strength(s) 50MG 3.2MG 50MG 3.2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250mL 250mL
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-10-12 2017-10-12
Actual start date 2017-10-12 2017-10-12
Estimated end date 2018-02-06 2018-02-12
Actual end date 2018-02-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Shortage is resolved. Returned to normal supply. Supply is available but not enough to meet excess demand during the shortage period. Product allocation controls are in place to control excess demand.
Health Canada comments